Pharmacokinetics
Propranolol and atenolol pharmacokinetics in obese patients reported
Published in Obesity and Diabetes Week, September 29th, 2003
"The lipophilic beta-adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients," scientists in Poland report.
"A total of 43 subjects were allocated into three study groups: healthy, lean, normolipemic volunteers; obese normolipemic subjects; and obese patients with lipid disorders," said Jerzy Wojcicki and colleagues at the Pomeranian Academy of Medicine. "A...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Body Mass Index
BMI affects weight changes and mortality of patients on hemodialysis - Diabetes Research
New studies will focus on action of insulin - Diabetes Therapy
Treatment of diabetes during pregnancy reviewed - Obesity
Overweight patients twice as likely to have second heart attack - Obesity Risk Factor
Obesity associated with depression in women but not in men - Type 2 Diabetes Pathogenesis
History of maturity-onset diabetes of the young described - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
